corporate
 
 

Simbiosys is a cell-biology platform company that is unique in leveraging a highly-focused core platform to deliver innovative solutions for application-oriented verticals in the pharmaceutical and diagnostic industries.

We offer the following solutions that cover diabetes, obesity and cancer drug discovery; in-vitro ADME; assay development; cell culture and cell banking; cell line development; recombinant protein expression; molecular biology services; and natural product testing.
Diabetes Assays (therapeutic target-based)   Cell Line Development
PTP1B   Recombinant cell lines
DPP 4 (and selectivity over DPP 8, 9)   Monoclonal Antibody
Glucose Uptake   Primary cell immortalization
Insulin Secretion (Pancreatic Islet Isolation)       hTERT
            SV40
Obesity Assays (therapeutic target-based)      
CB1 (and selectivity over CB2)   Molecular Biology
5-HT2c Serotonin Receptor   PCR amplification
Pancreatic Lipase   Cloning / Sub-cloning
Lipolysis      
Adipogenesis   Bioinformatics
Pre-adipocyte Differentiation   MetPath™
      OncoPath™
Cancer Assays (therapeutic approach)   Custom Pathway Databases
DNA damage   Secondary microarray data
Cell proliferation     analysis
Apoptosis      
Protein tyrosine kinases   Natural Product Testing
Anti-angiogenesis   bioACTIV™
Glycolysis inhibition   bioQC™
         
Tissue Research      
Gene Expression      
Protein Expression    
     
Custom Assay Development  
  Primary cell isolation      
Adipocytes      
Myocytes  
Endothelial  
Sebocytes  

 
 
Assay Development
Cell Isolation & Banking
Cell Line Development
Natural Product Testing
Molecular Biology
Bioinfomatics

 
Home Quality of Research Delivery Model White Papers Site Map FAQs